Artificial intelligence and triple negative breast cancer: can pathomics help oncologists?
Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous subtype of breast cancer with limited targeted therapies and poor prognosis. Recent advances in digital pathology and artificial intelligence (AI) are transforming traditional, qualitative histopathology into quantitative, data-driven analysis. Wit...